IHS Chemical Week

People & Business :: Emerging Companies

DSM to Invest in Anti-Infectives in China

10:00 AM MDT | April 3, 2009 | DEEPTI RAMESH

DSM has signed a contract with North China Pharmaceutical Group Corp. (NCPC; Shijiazhuang) to establish three separate joint ventures with NCPC involving nutritional products and anti-infectives in China. DSM says it will invest a total of $110 million in these initiatives. DSM says it will acquire a minority stake of about 10% in NCPC, a manufacturer of vitamins and antibiotics. The companies will establish a nutrition product jv for vitamin C and two jv’s involving anti-infectives active pharmaceutical ingredients and intermediates. DSM will hold a 51%...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa